Home » Stocks » AKYA

Akoya Biosciences, Inc. (AKYA)

Stock Price: $22.97 USD -3.08 (-11.82%)
Updated Apr 19, 2021 4:00 PM EDT - Market closed
After-hours: $22.57 -0.40 (-1.74%) Apr 19, 4:34 PM
Market Cap 819.78M
Revenue (ttm) 42.44M
Net Income (ttm) -16.71M
Shares Out 35.69M
EPS (ttm) -0.47
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 19
Last Price $22.97
Previous Close $26.05
Change ($) -3.08
Change (%) -11.82%
Day's Open 24.60
Day's Range 22.60 - 25.23
Day's Volume 578,316
52-Week Range 22.60 - 28.96

News

Hide News

MARLBOROUGH, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the pricing of its initial public offering of 6,580...

4 days ago - GlobeNewsWire

Akoya Biosciences, Inc. has filed to go public with an IPO on the NASDAQ.

3 weeks ago - SEC

About AKYA

Akoya Biosciences is an innovative life sciences technology company whose mission is to deliver a revolutionary new class of spatially derived biomarkers that empower life sciences researchers to better understand disease and clinicians to improve patient outcomes. Spatial biology refers to a rapidly evolving technology that enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single cell resolution, enabling advancements in their understanding of disease progre... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Apr 16, 2021
CEO
Brian McKelligon
Employees
169
Stock Exchange
NASDAQ
Ticker Symbol
AKYA
Full Company Profile

Financial Performance

In 2020, AKYA's revenue was $42.44 million, an increase of 0.49% compared to the previous year's $42.24 million. Losses were -$16.71 million, 13.3% more than in 2019.

Financial Statements